Celldex Therapeutics, Inc (CLDX)
Celldex Therapeutics (CLDX) stock hits a 52-week high driven by positive trial data and analyst upgrades. However, recent net losses and price volatility are causing concern among investors.
About Celldex Therapeutics, Inc
Celldex Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for cancer and other diseases.
Celldex Therapeutics, Inc uses the ticker $CLDX for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Celldex Therapeutics, Inc (CLDX) social dominance is up 309.09% from the previous week.
- Celldex Therapeutics, Inc (CLDX) Galaxy Score™ is up 31.43% from the previous week.
- Celldex Therapeutics, Inc (CLDX) creators is up 54.55% from the previous week.
- Celldex Therapeutics, Inc (CLDX) engagements is up 224.91% from the previous month.
- Celldex Therapeutics, Inc (CLDX) mentions is up 78.21% from the previous week.
- Celldex Therapeutics, Inc (CLDX) posts created is up 111.11% from the previous week.
- Celldex Therapeutics, Inc Price hit a 52-Week high of $32.60 for the hour
Price: $23.20
Price 24-Hour Time-Series Raw Data
The stock's price action is bullish, reaching a 52-week high due to positive trial data and analyst upgrades, as evidenced by the 16.78% gain over the past [--] days. However, concerns about recent net losses and price volatility are tempering this upward trend, reflected in the 24-hour gain of -1.24%.
24-Hour: 0.72% 7-Day: -6.63% 30-Day: -9.69%
1-Year High: $29.80 on 2025-12-08
1-Year Low: $15.10 on 2025-04-08
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Celldex Therapeutics, Inc (CLDX) is currently AltRank #1,064 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] [---]
[--] Month: [-----] [---]
[--] Months: [-----] +708
[--] Year: [-----] +175
1-Year High: [-----] on 2026-02-11
1-Year Low: [---] on 2025-12-21
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +11
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-04-11
1-Year Low: [--] on 2025-12-26
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +93%
[--] Month: [-------] +225%
[--] Months: [-------] -31%
[--] Year: [---------] -11%
1-Year High: [-------] on 2025-08-20
1-Year Low: [--] on 2025-04-13
Engagements by network (24h): X: [-----] Reddit: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +78%
[--] Month: [---] +40%
[--] Months: [-----] -30%
[--] Year: [-----] +25%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-13
Mentions by network (24h): X: [--] Reddit: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Celldex Therapeutics, Inc (CLDX) in the last [--] hours which is down 21% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [--] +55%
[--] Month: [--] +13%
[--] Months: [---] -55%
[--] Year: [-----] +62%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-13
The most influential creators that mention Celldex Therapeutics, Inc in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | [--] | [------] | [--] | [-----] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @RahulGandi86155 | [--] | [--] | [--] | [--] |
| @DavidGanno28735 | [--] | [--] | [--] | [--] |
| @hotterc45506 | [--] | [--] | [--] | [--] |
| @doepke_michel | [--] | [-----] | [--] | [--] |
| @mariostario2019 | [--] | [--] | [--] | [--] |
| @SMALLCAPSAXIS | [--] | [---] | [--] | [--] |
| @DaytradingStars | [--] | [--] | [--] | |
| @ChrisJones52784 | [--] | [--] | [--] | [--] |
Sentiment: 86%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 86%
Daily Average: 78%
[--] Week: 100% no change
[--] Month: 75% -17%
[--] Months: 75% +14%
[--] Year: 75% +15%
1-Year High: 100% on 2025-02-26
1-Year Low: 13% on 2025-11-29
Most Supportive Themes:
- Positive Trial Data: (40%) Recent positive trial data has been a significant driver for Celldex Therapeutics, boosting investor confidence and contributing to the stock's upward trend.
- Analyst Upgrades: (30%) Upgrades from financial analysts have further bolstered the positive sentiment surrounding Celldex Therapeutics, influencing its current market performance.
Most Critical Themes:
- Net Losses: (20%) Despite positive developments, Celldex Therapeutics has reported recent net losses, which are a point of concern for investors and may temper the stock's rally.
- Price Volatility: (10%) The stock has experienced notable price volatility, a factor that could introduce risk for investors and influence short-term trading strategies.
Social Dominance: 0.00349%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00349%
Daily Average: 0.00652%
[--] Week: 0.018% +0.014%
[--] Month: 0.013% +0.0089%
[--] Months: 0.013% -0.0019%
[--] Year: 0.013% +0.0049%
1-Year High: 0.034% on 2025-06-29
1-Year Low: 0.001% on 2025-12-25
Market Dominance: 0.00173%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00173%
Daily Average: 0%
1-Year High: 0.045% on 2025-03-31
1-Year Low: 0.00166% on 2025-04-09
Market Cap: $1,532,324,801
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,532,324,801
Daily Average: $1,532,858,908
[--] Week: $1,528,337,833 -7.30%
[--] Month: $1,528,337,833 -10%
[--] Months: $1,528,337,833 +10%
[--] Year: $1,528,337,833 +1.50%
1-Year High: $1,980,194,236 on 2025-12-08
1-Year Low: $1,004,387,060 on 2025-04-08
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing